Sign in

CIK 0001672619

  • Non-accelerated filer

Enliven Therapeutics, Inc.

Sign in to watch
Ticker
ELVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
811523849
Phone
+1 650-547-5814
Business address
205 PARK ROAD, BURLINGAME, CA, 94010
Former names
IMARA Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,819,567
in 6 filings, $1.2M under 10b5-1 plans

Net −$1,819,567. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-06-02 MOTT DAVID M Director Grant or award · Stock Options (Right to Buy) +8,500 8,500
2022-02-23 MOTT DAVID M Director Purchase +35,257 $1.46 $51K 229,224
2022-02-22 MOTT DAVID M Director Purchase +65,817 $1.56 $103K 193,967
2022-02-18 MOTT DAVID M Director Purchase +50,398 $1.30 $66K 128,150
2022-02-17 MOTT DAVID M Director Purchase +14,595 $1.17 $17K 77,752
2022-02-16 MOTT DAVID M Director Purchase +11,779 $1.20 $14K 63,157
2022-02-15 MOTT DAVID M Director Purchase +19,552 $1.20 $23K 51,378
2022-02-14 MOTT DAVID M Director Purchase +8,500 $1.18 $10K 31,826
2022-02-11 MOTT DAVID M Director Purchase +14,573 $1.23 $18K 23,326
2022-02-10 MOTT DAVID M Director Purchase +8,753 $1.29 $11K 8,753
2021-06-29 MOTT DAVID M Director Grant or award · Stock Option (right to buy) +7,728 7,728
2020-03-16 MOTT DAVID M Director Grant or award · Stock Option (right to buy) +15,457 15,457

Page 1 of 1 · 12 trades